Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer [Phase 3]
Phase 3 clinical trial update evaluating chemosensitivity testing to guide treatment in patients with stage III or stage IV ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer [Phase 2]
Phase 2 trial updating the activity of TroVax versus placebo in relapsed asymptomatic ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial updating apatinib with albumin-bound paclitaxel in platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-02Clinical Trial Update: Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of alisertib in combination with weekly paclitaxel in East Asian patients with advanced solid tumors and ovarian cancer was te…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer [Phase 3]
Phase 3 trial updating maintenance niraparib versus placebo in platinum-sensitive ovarian cancer has completed; results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer [Phase 2]
Phase 2 trial update for anlotinib in patients with platinum resistant or refractory ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer [Phase 3]
Phase 3 trial evaluating carboplatin plus paclitaxel with or without continued low-dose paclitaxel in early-stage ovarian cancer completed; …
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with or without pazopanib in persistent or recurrent ovarian, fallopian tube, or peritoneal cavity cance…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MESO-CAR T cell therapy for relapsed and refractory epithelial ovarian cancer. Status not disclosed in…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of PANVAC-V and PANVAC-F vaccines with sargramostim in advanced cancers (adenocarcinoma, colorectal cancer; other listed con…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy [Phase 2]
Phase 2 clinical trial update for intraperitoneal hyperthermic chemotherapy in several gynecologic and related cancers; current status not s…
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian [Phase 2]
Phase 2 clinical trial update evaluating adoptive cell therapy after a reduced intensity, non-myeloablative lymphodepleting induction in met…
-
FDA approval · 2019-04-01FDA Approved: DOCETAXEL — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Docetaxel from Dr. Reddy's Laboratories Inc., authorizing the generic product under the approved…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial investigating ABT-263 as a single agent in women with platinum-resistant or refractory recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing two first-line regimens (carboplatin-paclitaxel or oxaliplatin-capecitabine) with or without bevacizumab. The stud…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating TRC105 in recurrent ovarian, fallopian tube, or primary peritoneal carcinoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer [Phase 2]
Phase 2 trial update on efficacy and safety of albumin-bound paclitaxel as first-line chemotherapy for ovarian cancer.
-
CLINICAL_TRIALS withdrawal · 2019-02-20Clinical Trial Update: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating metformin hydrochloride with carboplatin and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers [Phase 1]
Phase 1 trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or primary peritoneal cancers; trial completed with result…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients [NA]
This completed clinical trial evaluated whether geriatrician-led interventions can improve chemotherapy delivery in vulnerable elderly oncol…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction [Phase 1, Phase 2]
This Phase 1/2 clinical trial tests best supportive care with either cisplatin or paclitaxel for patients with ovarian cancer, primary perit…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery [Phase 1]
This update reports the completion of a Phase 1 exploratory study evaluating the folic acid-tubulysin conjugate EC1456 in ovarian cancer pat…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing trabectedin plus doxorubicin liposome vs doxorubicin liposome alone in advanced-relapsed epithelial ovarian, primary…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer [Phase 1]
A Phase 1 trial evaluating a combination chemotherapy approach with bone marrow transplantation and peripheral stem cell transplantation for…
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies [Phase 1]
Phase 1 clinical trial update evaluating COTI-2 as a monotherapy or in combination for multiple malignancies, sponsored by Critical Outcome …